Zhang Lab

National University of Singapore

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	5-hydroxytryptamine receptor 4
Species	Cavia porcellus (Guinea pig)
Gene	HTR4
Synonym	5-HT-4 5-HT4 Serotonin receptor 4
Disease	N/A for non-human GPCRs
Length	388
Amino acid sequence	MDKLDANVSSKEGFGSVEKVVLLTFLSAVILMAILGNLLVMVAVCRDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWVYGEMFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPMFISFLPIMQGWNNIGIVDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHARQIQVLQRAGAPAEGRPQPADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQLWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDTVECGGQWESQCHPAASSPLVAAQPIDT
UniProt	O70528
Protein Data Bank	N/A
GPCR-HGmod model	N/A
3D structure model	No available structures or models
BioLiP	N/A
Therapeutic Target Database	N/A
ChEMBL	CHEMBL5017
IUPHAR	N/A
DrugBank	N/A

Ligand

Name	doxorubicin
Molecular formula	C27H29NO11
IUPAC name	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
Molecular weight	543.525
Hydrogen bond acceptor	12
Hydrogen bond donor	6
XlogP	1.3
Synonyms	10336-EP2277568A2 Caelyx 13171-EP2298780A1 SCHEMBL3243 10336-EP2292280A1 CHEMBL53463 13171-EP2308839A1 10336-EP2298748A2 DB00997 14-Hydroxydaunorubicine 10336-EP2301928A1 Doxorubicin hydrochloride (hydrochloride salt) 25316-40-9 (hydrochloride) 10336-EP2305671A1 Doxorubicina [INN-Spanish] AB1009243 10336-EP2311453A1 FI 106 (1s,3s)-3,5,12-Trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranoside; Adriamycin; Doxorubicin Adriablastin 10336-EP2316452A1 Hydroxydaunomycin hydrochloride (hydrochloride salt) (7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4-methoxy-6,9,11-tris(oxidanyl)-9-(2-oxidanylethanoyl)-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride Adriamycin RDF 13171-EP2270008A1 MolPort-006-124-025 (8S-cis)-10-(3-Amino-2,3,6-Tr ideoxy-alpha-L-Lyxo-Hexopyranosyl)Oxy-7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-5,12-Naphthacenedione Adriblastina (TN) 13171-EP2289892A1 NCGC00024415-42 10336-EP2270018A1 BP-23114 13171-EP2295413A1 Probes1_000151 13171-EP2298736A1 Resmycin 10336-EP2277865A1 Cantide + adriamycin 13171-EP2305642A2 ThermoDox 10336-EP2292617A1 Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120 13171-EP2316832A1 10336-EP2298768A1 DOX-SL 23214-92-8 10336-EP2302383A2 Doxorubicin-hLL1 45970-EP2287156A1 10336-EP2308562A2 Doxorubicinum AC1Q29OJ 10336-EP2311825A1 GTPL7069 (7S,9R)-7-[(2S,4S,5S,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione Adriacin (hydrochloride salt) 10336-EP2316834A1 JT9100000 (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Adriamycin semiquinone 13171-EP2275102A1 NCGC00024415-35 1,2,3,4,6,11-Hexahydro-4beta,5,12-trihydroxy-4-(hydroxyacetyl)-10-methoxy-6,11-dioxonaphthacen-1beta-yl-3-amino-2,3,6-trideoxy-alpha-L-lyxohexopyranoside AKOS015951330 13171-EP2292614A1 NSC 123127 10336-EP2272832A1 BRD-K92093830-003-25-8 C-23275 13171-EP2298768A1 Rubex (TN) 10336-EP2281815A1 CHEBI:28748 13171-EP2305689A1 UNII-80168379AG 10336-EP2295426A1 D07VLY 13171-EP2316937A1 10336-EP2301536A1 Doxorubicin (USAN/INN) 25311-50-6 10336-EP2305640A2 Doxorubicin-P4/D10 conjugate 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 10336-EP2308855A1 EINECS 245-495-6 (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside ADR 10336-EP2311840A1 HY-15142A (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione Adriamycin PFS (hydrochloride salt) 13171-EP2269989A1 MCULE-4188577717 (8S,10S)-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione Adriblastina 13171-EP2281815A1 NCGC00024415-40 10336-EP2270008A1 BDBM22984 13171-EP2295407A1 Prestwick2_000438 10336-EP2277566A2 10336-EP2277569A2 Caelyx (liposomal doxorubicin) 13171-EP2301933A1 SMP1_000106 10336-EP2292614A1 cid_443939 13171-EP2308861A1 10336-EP2298764A1 DM2 14D928 10336-EP2301933A1 Doxorubicin [USAN:INN:BAN] 29042-30-6 10336-EP2305679A1 Doxorubicine 10336-EP2311455A1 FT-0601614 (1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-(3-amino-2,3,6-tridesoxy-alpha-L-lyxo-hexopyranosid) adriablastine (hydrochloride salt) 10336-EP2316832A1 Hydroxydaunorubicin (7S,9S)-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride Adriamycin RDF (hydrochloride salt) 13171-EP2270018A1 Myocet (8S-cis)-10-(3-Amino-2,3,6-Trideoxy-alpha-L-Lyxo-Hexopyranosyl)Oxy-7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-5,12-Naphthacenedione adriblatina (hydrochloride salt) 13171-EP2292227A2 NCI-C01514 10336-EP2270505A1 BPBio1_000502 13171-EP2295416A2 Probes2_000129 13171-EP2298746A1 Rubex 10336-EP2277876A1 CC-23807 13171-EP2305671A1 TLC D-99 10336-EP2295055A2 CS-2759 13171-EP2316833A1 10336-EP2298778A1 Doxil 23257-17-2 10336-EP2305243A1 Doxorubicin-hLL1 conjugate 45970-EP2311807A1 10336-EP2308812A2 Doxorubicinum [INN-Latin] adiblastine (hydrochloride salt) 10336-EP2311827A1 HMS2089H06 (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione Adriamycin 10336-EP2371811A2 LMPK13050001 (8S,10S)-10-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Adriblas tina 13171-EP2277865A1 NCGC00024415-37 10-((3-Amino-2,3,6-trideoxy-alpha-L-lyso-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione AN-17965 13171-EP2292615A1 Prestwick0_000438 10336-EP2275420A1 BSPBio_000456 10336-EP2277567A1 C01661 13171-EP2298772A1 SB21799 10336-EP2289892A1 13171-EP2308833A2 ZINC3918087 10336-EP2295427A1 D0VW5S 14-Hydroxydaunomycin 10336-EP2301538A1 Doxorubicin citrate 25316-40-9 10336-EP2305642A2 Doxorubicina 80168379AG 10336-EP2308861A1 Farmablastina (hydrochloride salt) (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside adr iablatina (hydrochloride salt) 10336-EP2311842A2 Hydroxydaunomycin hydrochlor ide (hydrochloride salt) (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride Adriamycin PFS (TN) 13171-EP2269994A1 MLS000028393 (8S-cis)-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione Adriblastina (hydrochloride salt) 13171-EP2286812A1 NCGC00024415-41 10336-EP2270014A1 BDBM32022 13171-EP2295412A1 Prestwick3_000438 RDF Rubex 10336-EP2277570A2 Caelyx (TN) 13171-EP2305640A2 SPBio_002395 10336-EP2292615A1 Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74 13171-EP2311827A1 10336-EP2298765A1 DOX 10336-EP2302382A2 Doxorubicin(Adriamycin) 45970-EP2275413A1 10336-EP2305689A1 Doxorubicine [INN-French] AC1L1M5T 10336-EP2311808A1 GR-319 (1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside adriablatina (hydrochloride salt) 10336-EP2316833A1 Hydroxydaunorubicin hydrochloride (hydrochloride salt) (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracen Adriamycin RDF (TN) 13171-EP2270505A1 Myocet (TN) (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione Aerosolized Doxorubicin 13171-EP2292233A2 NDC 38242-874 10336-EP2272827A1 BRD-K92093830-003-04-3 13171-EP2298305A1 13171-EP2298748A2 Rubex (hydrochloride salt) 10336-EP2280012A2 CCRIS 739 13171-EP2305679A1 Triferric doxorubicin 10336-EP2295416A2 D03899 13171-EP2316834A1 10336-EP2298780A1 24385-08-8 10336-EP2305250A1 Doxorubicin-P4/D10 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)- 10336-EP2308833A2 DTXSID8021480 ADM 10336-EP2311829A1 HSDB 3070 (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-9-glycoloyl-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinone;hydrochloride Adriamycin PFS 10336-EP2374454A1 LS-165655 (8S,10S)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Adriblastin 13171-EP2277876A1 NCGC00024415-38 10-((3-Amino-2,3,6-trideoxy-D-lyxohexopyranosyl)oxy)-8-glycolcyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione AOJJSUZBOXZQNB-TZSSRYMLSA-N 13171-EP2292617A1 Prestwick1_000438 10336-EP2277565A2 BSPBio_001031 [ Show all ]
Inchi Key	AOJJSUZBOXZQNB-TZSSRYMLSA-N
Inchi ID	InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1
PubChem CID	31703
ChEMBL	CHEMBL53463
IUPHAR	N/A
BindingDB	22984
DrugBank	N/A
Structure SDF download
Lipinski's druglikeness	This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons.

Experimental Data

Parameter	Value	Reference	Database source
IC50	12468.0 nM	DrugMatrix in vitro pharmacology data	ChEMBL
Ki	2078.0 nM	DrugMatrix in vitro pharmacology data	ChEMBL

zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417